Related Articles
Outcome of initial lenvatinib treatment in patients with unresectable anaplastic thyroid cancer
PD‑L1 expression and immune cells in anaplastic carcinoma and poorly differentiated carcinoma of the human thyroid gland: A retrospective study
Potential synergistic effects of sorafenib and CP‑31398 for treating anaplastic thyroid cancer with p53 mutations
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience
Elucidation of the molecular mechanisms of anaplastic thyroid carcinoma by integrated miRNA and mRNA analysis